Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada

Contraception

Volumn 82, Issue 6, 2010, Pages 497-502

  Reid, Robert L ^a   Fortier, Michel P ^b   Smith, Lynne ^c   Mirkin, Sebastian ^c   Grubb, Gary S ^c   Constantine, Ginger D ^c  

^a QUEEN S UNIVERSITY   (Canada)

^b Clinique de Recherche en Sante des Femmes   (Canada)

^c PFIZER INC   (United States)

Author keywords

Bleeding; Continuous oral contraceptive; Ethinyl estradiol; Levonorgestrel; Safety

Indexed keywords

ESTRADIOL PLUS LEVONORGESTREL;

ABDOMINAL PAIN; ACNE; ADULT; AMENORRHEA; ANXIETY; ARTHRALGIA; ARTICLE; ASTHENIA; BACKACHE; BLEEDING; BRONCHITIS; CANADA; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG SAFETY; DRUG WITHDRAWAL; DYSMENORRHEA; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HUMAN; HUMAN EXPERIMENT; INFECTION; INSOMNIA; LOW DRUG DOSE; MENSTRUATION; METRORRHAGIA; MIGRAINE; MYALGIA; NAUSEA; NORMAL HUMAN; ORAL CONTRACEPTION; PAIN; PANIC; PATIENT SATISFACTION; PHARYNGITIS; PHASE 3 CLINICAL TRIAL; RHINITIS; SIDE EFFECT; SINUSITIS; SPOTTING; SUICIDE ATTEMPT; UPPER RESPIRATORY TRACT INFECTION; VAGINA BLEEDING; VAGINA CANDIDIASIS; VAGINITIS; WEIGHT GAIN;

ADOLESCENT; ADULT; AMENORRHEA; CANADA; CLINICAL TRIALS, PHASE III AS TOPIC; CONTRACEPTIVES, ORAL, COMBINED; DOSAGE FORMS; ETHINYL ESTRADIOL; FEMALE; HUMANS; INCIDENCE; LEVONORGESTREL; MENORRHAGIA; METRORRHAGIA; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PATIENT SATISFACTION; YOUNG ADULT;

EID: 78249232587     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.06.002     Document Type: Article

References (7)

1. Kwiecien M., Edelman A., Nichols M.D., and Jensen J.T. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial Contraception 67 2003 9 13
2. Sulak P.J., Cressman B.E., Waldrop E., Holleman S., and Kuehl T.J. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms Obstet Gynecol 89 1997 179 183
3. Guilbert E., Boroditsky R., and Black A. Canadian consensus guidelines on continuous and extended hormonal contraception, 2007 J Obstet Gynaecol Can 195 2007 S1 S32
4. Anderson F.D., Gibbons W., and Portman D. Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial Am J Obstet Gynecol 195 2006 92 96
5. Archer D.F., Jensen J.T., Johnson J.V., Borisute H., Grubb G.S., and Constantine G.D. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: Phase 3 study results Contraception 74 2006 439 445
6. Teichmann A.T., Kluft C., Grubb G., Constantine G., and Spielmann D. Comparative trial of continuous-use and 21-day cyclic levonorgestrel and ethinyl estradiol oral contraceptive Obstet Gynecol 107 Suppl 2006 12S
7. Belsey E.M. Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Adv Contracept 7 1991 257 270